Menu
sharewise sharewise
Log in
Sign up
Log in
Sign up
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
Top Performance

Predictions

buy
Sangamo Therapeutics Inc.

Start price
Target price
Perf. (%)
€1.12
10.05.23
-
10.05.24
9.93%
15.05.23

Risky Investment
Wolf_of_WS 
10.05.23 50%
buy
Novavax Inc.

Start price
Target price
Perf. (%)
€9.43
09.05.23
€12.00
09.05.24
-54.40%
10.05.24

Could be worthwhile Investment >10% per year
melinda 
09.05.23 50%
buy
Intra-Cellular Therapies Inc.

Start price
Target price
Perf. (%)
€57.00
09.05.23
-
09.05.24
10.70%
31.01.24

Saftman 
09.05.23 50%
sell
Trevena Inc.

Start price
Target price
Perf. (%)
€2.01
08.05.23
-
08.05.24
-36.06%
14.05.23

Vassago1 
08.05.23 50%
sell
Oragenics Inc.

Start price
Target price
Perf. (%)
€7.60
07.05.23
-
07.05.24
0.00%
08.05.24

StockNews.com 
07.05.23 50%
buy
Acorda Therapeutics Cdt

Start price
Target price
Perf. (%)
€0.61
07.05.23
-
07.05.24
-22.31%
08.05.24

StockNews.com 
07.05.23 50%
sell
Tonix Pharmaceuticals Holding Corp.

Start price
Target price
Perf. (%)
€2.86
07.05.23
-
07.05.24
-88.84%
08.05.24

StockNews.com 
07.05.23 50%
buy
Alnylam Pharmace.

Start price
Target price
Perf. (%)
€193.40
06.05.23
-
06.05.24
-26.81%
07.05.24

StockNews.com 
06.05.23 50%
buy
Eli Lilly Corp.

Start price
Target price
Perf. (%)
€388.00
06.05.23
-
06.05.24
83.76%
07.05.24

StockNews.com 
06.05.23 50%
sell
AEterna Zentaris Inc.

Start price
Target price
Perf. (%)
€2.95
06.05.23
-
06.05.24
-36.50%
07.05.24

StockNews.com 
06.05.23 50%
buy
Eli Lilly Corp.

Start price
Target price
Perf. (%)
€388.00
05.05.23
€395.00
05.05.24
3.52%
12.05.23

Higher EBIT margin than peer group
Differentiated customer and product portfolio
Medium risks for its business
Top 10 in its market
Traumtanz 
05.05.23 50%
sell
Aceragen Inc.

Start price
Target price
Perf. (%)
€2.22
03.05.23
-
03.05.24
-27.03%
11.05.23

Global_Player 
03.05.23 50%
buy
Immunogen Inc.

Start price
Target price
Perf. (%)
€10.66
03.05.23
€14.47
03.05.24
171.76%
04.05.24

Piper Sandler 
03.05.23 50%
buy
Pulmatrix Inc.

Start price
Target price
Perf. (%)
€2.76
03.05.23
-
03.05.24
-9.60%
15.05.23

Could be very worthwhile Investment >20% year
Global_Player 
03.05.23 50%
sell
Agenus Inc.

Start price
Target price
Perf. (%)
€1.30
02.05.23
€1.00
02.05.24
4.32%
13.05.23

Probably not worthwhile Investment
High valuation
Low dividend yield expected
negative Cash Flow expected
kostojunior 
02.05.23 0%
buy
Aceragen Inc.

Start price
Target price
Perf. (%)
€1.52
02.05.23
€3.00
02.05.24
-70.66%
13.02.24

Could be worthwhile Investment >10% per year
melinda 
02.05.23 20%
sell
Avenue Therapeutics Inc.

Start price
Target price
Perf. (%)
€0.87
02.05.23
-
02.05.27
-84.52%
11.03.24

Probably not worthwhile Investment
Lutz69 
02.05.23 50%
buy
Biogen Inc.

Start price
Target price
Perf. (%)
€281.00
01.05.23
€317.14
01.05.24
-28.01%
02.05.24

Guggenheim 
01.05.23 50%
buy
Stoke Therapeutics Inc

Start price
Target price
Perf. (%)
€8.85
01.05.23
-
01.05.24
20.90%
02.05.24

Bank of America Co. 
01.05.23 50%
sell
Agenus Inc.

Start price
Target price
Perf. (%)
€1.37
01.05.23
-
01.05.24
-69.70%
02.05.24

Innovative
overvalued
Risky Investment
High risks for its business
ReynadJ 
01.05.23 0%
sell
Seres Therapeutics Inc

Start price
Target price
Perf. (%)
€4.56
01.05.23
-
01.05.24
-77.85%
11.12.23

Probably not worthwhile Investment
Lokrim 
01.05.23 20%
buy
Riot Blockchain Inc.

Start price
Target price
Perf. (%)
€9.48
30.04.23
-
30.04.24
29.73%
12.01.24

Could be worthwhile Investment >10% per year
Very high cyclical dependencies
Gilbert 
30.04.23 0%
sell
Bellicum Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€0.23
30.04.23
-
30.04.24
-30.34%
01.05.24

StockNews.com 
30.04.23 50%
sell
Cellectar BioSciences Inc.

Start price
Target price
Perf. (%)
€1.41
30.04.23
-
30.04.24
117.02%
01.05.24

StockNews.com 
30.04.23 50%
sell
Cyclacel Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€0.50
30.04.23
-
30.04.24
-65.32%
01.05.24

StockNews.com 
30.04.23 50%